Health care stocks were mixed premarket Tuesday with the Health Care Select Sector SPDR Fund (XLV) down 1.2% and the iShares Biotechnology ETF (IBB) recently up 0.3%.
UnitedHealth Group (UNH) shares declined by over 9% after the company suspended its 2025 outlook and named Stephen Hemsley as chief executive, effective immediately, succeeding Andrew Witty.
CNS Pharmaceuticals (CNSP) shares surged by over 92% after the company said it has acquired from Cortice Biosciences orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.
Legend Biotech (LEGN) shares were up over 1% after the company reported a narrower Q1 adjusted net loss as revenue more than doubled during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.